Skip to main content
. 2019 Sep 6;7(3):E568–E572. doi: 10.9778/cmajo.20190040

Table 3:

Laboratory values, drug use and comorbidities of patients with chronic kidney disease

Variable No. (%) of patients*
n = 1859
Laboratory values, mean ± SD
 Glycated hemoglobin concentration 8.3 ± 2.3
 Low-density lipoprotein cholesterol level, mmol/L 2.1 ± 0.6
Drug use
 Statin 980 (52.7)
 Angiotensin-converting-enzyme inhibitor or angiotensin receptor blocker 619 (33.3)
Comorbidities
 Diabetes mellitus 1332 (71.6)
 Dyslipidemia 1313 (70.6)
 Hypertension 1098 (59.1)
2 comorbidities
 Diabetes + dyslipidemia 1069 (57.5)
 Diabetes + hypertension 877 (47.2)
 Hypertension + dyslipidemia 852 (45.8)
3 comorbidities
 Hypertension + diabetes + dyslipidemia 716 (38.5)

Note: SD = standard deviation.

*

Except where noted otherwise.

Some patients are represented in more than 1 group.